Kidney Transplant Rejection Market Projected to Advance Remarkably as a result of Increased Research and Development Activities and the Rise in the Patient Pool in the 7MM

Kidney Transplant Rejection Market Projected to Advance Remarkably as a result of Increased Research and Development Activities and the Rise in the Patient Pool in the 7MM

“Delveinsight Business Research LLP”
DelveInsight’s “Kidney Transplant Rejection Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the historical and forecasted epidemiology as well as the Kidney Transplant Rejection Market Size and Share in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Kidney transplant rejection is an immunological response that leads to inflammation with specific pathological changes in the allograft due to the recipient’s immune system recognizing the non-self (foreign) antigen in the allograft, with or without dysfunction of the allograft.

Factors that correlate with an increased risk of rejection of the renal allograft after the transplantation are prior sensitization, HLA mismatch, the advanced age of the donor, ABO incompatibility, previous episodes of rejections, type of transplant: (deceased donor has a higher rejection than a living transplant), inadequate immunosuppression, etc.

The standard way to detect rejection is a renal allograft biopsy, which accurately grades the severity of rejection, differentiates between different types, and guides the treatment. There are two major classifications for the histopathological

Get FREE sample copy at:

The Kidney Transplant Rejection Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Kidney Transplant Rejection market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Kidney Transplant Rejection treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

 Kidney Transplant Rejection Market

Kidney Transplant Rejection Market Key Facts

  • A recent analysis of more than 250,000 North American renal transplant recipients showed that despite modest improvements in long-term graft survival between 1989 and 2005, and improvements in graft half-life in the past decade for both living and deceased donor transplants, high attrition rates persist that stubbornly limit recent progress (Djamali et al., 2014).

  • According to DelveInsight’s analysis, there is no gender-based difference; however, older individuals have a higher incidence of kidney transplant rejection than young individuals.

  • In a study of 22,730 UK kidney recipients, 5,389 (23.7%) grafts failed within a median follow-up of 5 years. The two most frequent causes were death with a functioning graft (40.8%) and alloimmune pathology (25.0%) (Burton et al., 2018).

Key Benefits of Kidney Transplant Rejection Market Report

  • Kidney Transplant Rejection market report provides an in-depth analysis of Kidney Transplant Rejection Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

  • The report will help in developing business strategies by understanding the Kidney Transplant Rejection Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

  • The market report covers the Kidney Transplant Rejection current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

  • The report provides a detailed assessment of the Kidney Transplant Rejection market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Kidney Transplant Rejection Market

As per DelveInsight, the Kidney Transplant Rejection market size shall grow during the forecast period due to increased research and development (R&D) activities and a rise in the patient pool in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Kidney Transplant Rejection market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Kidney Transplant Rejection market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Kidney Transplant Rejection Epidemiology

The epidemiology section covers insights about the historical and current Kidney Transplant Rejection patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Kidney Transplant Rejection Epidemiology Segmentation

  • Total Cases of Kidney Transplant

  • Type-specific Cases of Kidney Transplant Rejection

  • Incident Cases of Kidney Transplant Rejection

  • Treatable Cases of Kidney Transplant Rejection

Kidney Transplant Rejection Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Kidney Transplant Rejection market or expected to get launched in the market during the study period. The analysis covers Kidney Transplant Rejection market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Kidney Transplant Rejection Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Kidney Transplant Rejection market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for Kidney Transplant Rejection emerging therapies.

The Kidney Transplant Rejection market size is expected to change in the coming years due to the increased incidence of end-stage renal disease for which kidney transplant remains to be the best therapy in terms of cost-effectiveness and advancement in immunosuppressive strategies and surgery.

Kidney Transplant Rejection Companies:

  • Novartis

  • Medeor Therapeutics

  • Talaris Therapeutics

  • CSL Behring

And others

Kidney Transplant Rejection Therapies covered in the report include:

  • CFZ533

  • MDR-101

  • MDR-102

  • FCR001

  • Clazakizumab

And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Kidney Transplant Rejection Competitive Intelligence Analysis

4. Kidney Transplant Rejection Market Overview at a Glance

5. Kidney Transplant Rejection Disease Background and Overview

6. Kidney Transplant Rejection Patient Journey

7. Kidney Transplant Rejection Epidemiology and Patient Population

8. Kidney Transplant Rejection Treatment Algorithm, Current Treatment, and Medical Practices

9. Kidney Transplant Rejection Unmet Needs

10. Key Endpoints of Kidney Transplant Rejection Treatment

11. Kidney Transplant Rejection Marketed Products

12. Kidney Transplant Rejection Emerging Therapies

13. Kidney Transplant Rejection Seven Major Market Analysis

14. Attribute Analysis

15. Kidney Transplant Rejection Market Outlook (7 major markets)

16. Kidney Transplant Rejection Access and Reimbursement Overview

17. KOL Views on the Kidney Transplant Rejection Market.

18. Kidney Transplant Rejection Market Drivers

19. Kidney Transplant Rejection Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:

Latest Reports By DelveInsight
Kidney Transplant Rejection Pipeline Insight
“Kidney Transplant Rejection Pipeline Insights, 2021” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Kidney Transplant Rejection Market.

Healthcare Blog By DelveInsight
Assistive Technology and Autism Spectrum Disorder
Assistive technology as a communication gateway is getting wider attention to address and improve issues related to Autism such as behavior, social skills, self-care, and other aspects of life. Assistive Technologies have several benefits and drawbacks associated with them. With each passing day, these technologies are getting better in functioning and in the coming years are expected to significantly improve the quality of life of children with ASD. Click to read more: Assistive Technology in Autism Spectrum Disorder (ASD)

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States